You are here

Eli Lilly

Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share

Fierce Pharma

Thu, 09/5/19 - 10:37 am

Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022

BioSpace

Mon, 09/2/19 - 12:25 pm

Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta

Pharmaforum

Fri, 08/30/19 - 10:48 am

non-squamous non-small cell lung cancer

Three strategies for managing loss of exclusivity successfully

Pharmaforum

Thu, 08/29/19 - 11:49 pm

market exclusivity

Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.

BioSpace

Thu, 08/29/19 - 08:16 pm

Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis

Endpoints

Mon, 08/26/19 - 09:33 am

monoclonal antibodies

ankylosing spondylitis

Olumiant from Lilly, Incyte clears third eczema study, but who will use it?

Endpoints

Mon, 08/26/19 - 09:29 am

Eli Lilly Wins Arbitration Hearing Against Adocia

BioSpace

Sun, 08/25/19 - 05:00 pm

intellectual property

Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

Pharmaforum

Wed, 08/21/19 - 10:37 am

Lilly’s first crowdsourced digital health contest seeks solutions for IBD

Fierce Pharma

Tue, 08/20/19 - 10:59 pm

innovation challenges

Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi

Reuters

Sat, 08/17/19 - 12:08 am

personalized medicine

Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt

Fierce Pharma

Tue, 08/13/19 - 11:40 am

Most insurers don't cover Eli Lilly's half-priced insulin

Beckers Hospital Review

Mon, 08/12/19 - 05:30 pm

Apple, Eli Lilly research whether devices can detect dementia signs

Medtech Dive

Fri, 08/9/19 - 10:40 am

Lilly shuffles executives overseeing oncology and M&A

Biopharma Dive

Thu, 08/8/19 - 11:28 pm

Eli Lilly confirms probe by New York’s Attorney General over insulin prices

CNBC

Mon, 08/5/19 - 10:34 pm

Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study

Endpoints

Mon, 08/5/19 - 10:59 am

clinical trials

chronic migraine

episodic migraine

3 Lung Cancer Stocks That Could Soar in September

Motley Fool

Mon, 08/5/19 - 12:04 am

New York investigating 3 insulin makers' pricing strategies

Beckers Hospital Review

Tue, 07/30/19 - 11:09 pm

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Fierce Pharma

Tue, 07/30/19 - 04:21 pm

Teva Pharmaceutical

Pages